Related Experiment Videos
Characterization of Mpl mutants using primary megakaryocyte-lineage cells from mpl(-/-) mice: a new system for Mpl
M Gaur1, G J Murphy, F J deSauvage
1Department of Laboratory Medicine, University of California, San Francisco 94143-0100, USA.
Abstract:
Mpl is the thrombopoietin (TPO) receptor. The current molecular understanding of how Mpl activation stimulates proliferation of megakaryocyte-lineage cells is based largely on the engineered expression of Mpl in nonmegakaryocyte-lineage cell lines. However, the relevance of these findings to Mpl signaling in primary megakaryocyte-lineage cells remains largely unknown. Therefore, a system was developed to study Mpl function in primary mpl(-/-) megakaryocyte-lineage cells. Expressing avian retroviral receptors on the surfaces of mammalian cells overcomes their natural block to avian retroviral infection; 815 bp of human GPIIb regulatory sequence was used to generate transgenic mice with megakaryocyte-lineage expression of the subgroup A avian leukosis virus receptor, TVA. Avian retroviral infection of unfractionated bone marrow from these mice is restricted to megakaryocyte-lineage cells. The transgenic mice were crossed to an mpl(-/-) background generating GPIIb-tva+mpl(-/-) mice. By using avian retroviruses to express wild-type or mutant Mpl on the surfaces of primary megakaryocyte-lineage cells, it was demonstrated that (1) the 10 membrane-proximal, cytoplasmic amino acids of Mpl are required for TPO-induced proliferation; (2) Y582F mutation confers a proliferative advantage over wild-type Mpl and imparts a constitutive anti-apoptotic signal; (3) truncating the 50 C-terminal Mpl amino acids reduces but does not eliminate TPO-induced mitogen-activated protein kinase activation, yet it does not alter the synergistic effect of stem cell factor on TPO-induced proliferation; and (4) TPO-induced proliferation of early, primary megakaryocyte-lineage cells does not require Stat-5 phosphorylation. The system reported provides an improved approach for Mpl structure-function studies, and the method can be applied to any hematopoietic lineage.
Insights
Researchers developed a novel system to study the thrombopoietin (TPO) receptor, Mpl, in primary megakaryocyte cells. This system reveals key Mpl regions essential for TPO-driven cell proliferation and survival.
Area of Science:
- Hematology
- Molecular Biology
- Cell Signaling
Background:
- Mpl is the thrombopoietin (TPO) receptor crucial for megakaryocyte development.
- Current understanding of Mpl signaling relies on non-primary cell models, limiting in vivo relevance.
- A system to study Mpl in primary megakaryocyte-lineage cells was needed.
Purpose of the Study:
- To develop a novel system for studying Mpl function in primary megakaryocyte-lineage cells.
- To elucidate the molecular mechanisms of Mpl activation and downstream signaling.
- To identify critical Mpl domains required for TPO-induced proliferation and survival.
Main Methods:
- Generated transgenic mice expressing the avian leukosis virus receptor (TVA) specifically in megakaryocyte-lineage cells using the GPIIb promoter.
- Crossed these mice with Mpl-deficient mice (mpl(-/-)) to create GPIIb-tva+mpl(-/-) mice.
- Utilized avian retroviruses to express wild-type or mutant Mpl in primary megakaryocyte-lineage cells for functional analysis.
Main Results:
- The 10 membrane-proximal cytoplasmic amino acids of Mpl are essential for TPO-induced proliferation.
- A Y582F mutation in Mpl enhances proliferation and provides constitutive anti-apoptotic signaling.
- Truncation of the 50 C-terminal Mpl amino acids partially reduces MAPK activation but preserves stem cell factor synergy.
- TPO-induced proliferation in early megakaryocyte-lineage cells does not depend on Stat-5 phosphorylation.
Conclusions:
- The developed avian retroviral system enables robust Mpl structure-function studies in primary megakaryocyte-lineage cells.
- Identified critical Mpl domains and signaling pathways involved in TPO-mediated megakaryopoiesis.
- This methodology is adaptable for studying other hematopoietic lineages and their receptors.